UCB · 1 day ago
Alternative Market Access Strategy Lead
Atlanta, Georgia, US
Full-time
Hybrid
Senior Level, Lead/Staff
$164K/yr - $216K/yr
10+ years expUCB is a global biopharmaceutical company focusing on neurology and immunology, and they are seeking an Alternative Market Access Strategy Lead. This role involves redefining how care reaches patients by developing strategies that enhance access to therapies while ensuring affordability and adherence.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Define the long-term vision and roadmap for DTP across UCB’s U.S. portfolio, ensuring alignment with patient centric access principles and corporate objectives
Build compelling business cases for investment in DTP initiatives, including pilots and scaleup strategies. Lead cross-functional integration for patient impact
Drive collaboration with Market Access, Trade, Policy, Legal, Compliance, Finance, IT/Digital, and Business Units to embed DTP into launch and lifecycle planning
Ensure seamless alignment between affordability solutions, reimbursement pathways, and patient support programs. Design and optimize patient-first models
Develop innovative DTP program designs that prioritize speed to therapy, affordability, and adherence while balancing risk/benefit to UCB
Serve as UCB’s subject matter expert on DTP partners and models
Use analytics to inform pricing constructs, channel strategies, and forecasting; anticipate DTP impact on gross to net and overall brand performance
Establish KPIs focused on patient outcomes and experience; monitor performance and recommend optimizations based on insights and ROI
Integrate DTP considerations into launch strategies for new products; lead test and learn pilots and scale successful models across brands
Partner with marketing and patient engagement teams to ensure messaging reflects the value of DTP for patients and caregivers
Align strategy with legal, compliance, and regulatory requirement
Champion innovation and continuous improvement
Qualification
Required
Bachelor's degree in Business, Health Policy, Pharmacy, Data/Analytics, or related field (MBA/MPH a plus)
10+ years of biopharma experience, with significant expertise in Market Access, Trade/Supply Chain, Channel Strategy, Patient Support/HUB, Specialty Pharmacy, Digital Health, or adjacent access and fulfillment domains
Preferred
Demonstrated ability to design or navigate patient access solutions that improve affordability, time to therapy, and adherence within U.S. healthcare channels
Strong analytical skills with fluency in forecasting, pricing constructs, gross-to-net drivers, and performance dashboards
Working knowledge of U.S. regulatory and compliance considerations relevant to patient access and distribution (for example, pharmacy and telehealth rules, price reporting sensitivities, privacy)
Proven ability to manage and influence a broad range of stakeholders across multiple functions and levels, driving alignment and execution on complex initiatives
Excellent communication, influence, and storytelling skills with a track record of aligning cross-functional teams around clear, patient-first decisions
Company
UCB
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease.
5001-10000 employees
Funding
Current Stage
Public CompanyTotal Funding
$201.75MKey Investors
Financière de Tubize SAPaul Capital
2022-05-23Post Ipo Equity· $100.96M
2015-05-13Post Ipo Equity· $0.79M
2009-12-22Post Ipo Equity· $100M
Leadership Team
Jean-Christophe Tellier
CEO
Stefanos Grammatikos
Senior Vice President - Head of CMC Development Sciences
Recent News
Company data provided by crunchbase